Every patient is unique. Your treatment should be, too.
Genomic testing identifies alterations in your genes that can help guide potential treatment options based on your unique diagnosis and test results. The information from your genomic test can support you and your doctor in making informed decisions on the best care along your journey. Your doctor will order the appropriate Tempus test.
Our tests
Disease Monitoring
Circulating tumor DNA (ctDNA) refers to cancer DNA that is present in the bloodstream. Minimal residual disease (MRD) testing can detect ctDNA that may be present after treatment, such as surgery or chemotherapy. This can help your doctor understand if there is any remaining disease following your treatment and help decide the best next steps.
Your doctor may also use this type of test to monitor your response to treatment, and guide potential adjustments to your care plan.
Your doctor may choose to order multiple disease monitoring tests to track your condition over time. Your doctor will select the MRD test that is right for you.
xM
Test using your blood sample
xM (NeXT Personal® Dx) test by Personalis
Test using your tumor tissue and blood sample
Biomarker Testing
Many cancers are caused by changes, or alterations, in our genes that may happen by chance or due to environmental factors. Biomarker testing, or molecular testing, looks for these specific alterations in our genes, which can help your doctors understand your unique cancer. Identifying alterations in your cancer may help your doctor choose therapies and personalize your treatment plan.
Your doctor will select the biomarker test that is right for you.
xT CDx, xT, or xR
Test using your tumor tissue
xF or xF+
Test using your blood sample
Hereditary risk
Hereditary cancers are caused by changes, or alterations, in our genes that may be inherited from a parent and passed on to one’s children. Genetic alterations that a person has had since birth can increase one's risk for developing cancer.
Hereditary testing, also called germline testing, is used to look for these changes in our genes to detect alterations that may increase you or your family’s risk for cancer. The most common hereditary cancers are breast, ovarian, colorectal, endometrial, prostate, and pancreatic cancer.
Your doctor will choose the hereditary test that is right for you.
CancerNext® or CancerNext-Expanded®
Test using your blood or saliva
Hear from patients
Financial Assistance
Tempus is committed to providing easy and affordable access to our tests and services.
All U.S.-based patients are eligible to apply for financial assistance regardless of insurance status. For international patients, we offer a self-pay option. For any questions, please email patients@tempus.com. Authorization for Medical Records: Through access.tempus.com, applicants are directed to our Notice and Authorization for Medical Records authorization form. This optional form allows us to request outcomes and other medical records from your health care providers. Please see the form for more information.
Applications for financial assistance can be submitted online at access.tempus.com ↗
If approved, the maximum out of pocket cost for testing will be provided immediately.
Please contact billing@tempus.com if you are concerned about out-of-pocket costs and would like to discuss your options.
RESOURCES
Learn more about Tempus.
Don’t see what you’re looking for? Check out our full document library or reach out to us at patients@tempus.com
*Eligibility for clinical trials is based on many factors such as your age, type of cancer, and your stage of cancer.